Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
This bill requires health insurance plans to cover at least one abuse-deterrent opioid pain medication for each active ingredient used to treat pain. It ensures patients pay no more for these abuse-deterrent options than for non-abuse-deterrent opioids (e.g., same copay level), and prohibits insurers from increasing patient costs or creating barriers to access these medications. The law also prevents prior authorization rules from forcing patients to try non-abuse-deterrent opioids first to get access to abuse-deterrent versions. It directly affects patients prescribed opioid pain medications and all health insurance plans operating in New York. The policy aims to improve access to medications designed to reduce opioid misuse without increasing out-of-pocket costs for patients.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 27, 2025
Last action Jan 7, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
2
Jan 7, 2026
Committee
REFERRED TO INSURANCE
upper
Mar 27, 2025
Committee
REFERRED TO INSURANCE
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Andrew Lanza
RRepublican/Conservative/Independence/Reform
Ask Maddy
·
AI policy assistant
Ask Maddy about S 6937
Scope: NY
Hi! I can help you understand S 6937. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline